Treatise:Mechanism and Practice

Factors influencing the characteristics of amniotic fluid sediment during mid-trimester amniocentesis and their impact on cell culture and pregnancy outcomes

  • Qin LI ,
  • Wei CHEN ,
  • Renhua WU ,
  • Jing YUAN ,
  • Yanping? HU
Expand
  • Prenatal Diagnosis Center,Department of Obstetrics and Gynecology,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,Anhui,China

Received date: 2026-05-18

  Revised date: 2026-06-15

  Accepted date: 2026-06-17

  Online published: 2026-08-13

Abstract

Objective To investigate the factors influencing the characteristics of amniotic fluid sediment following second-trimester amniocentesis for prenatal diagnosis, and to evaluate their impact on amniotic fluid cell culture and pregnancy outcomes, thereby providing a basis for clinical specimen processing, risk assessment, and genetic counseling. Methods A total of 2 489 pregnant women who underwent mid-trimester (18 - 24 weeks) amniocentesis for singleton pregnancies at the Prenatal Diagnosis Center of the First Affiliated Hospital of Anhui Medical University from January 2025 to December 2025 were retrospectively reviewed. Among them, 96 cases with distinct sediment characteristics were ultimately included. Based on the visual characteristics and volume of the sediment from 20 mL centrifuged amniotic fluid aliquots, patients were categorized into four groups: small-volume milky-white sediment (Group A, n = 20), large-volume milky-white sediment (Group B, n = 24), small-volume bloody sediment (Group C, n = 29), and small-volume dark-brown sediment (Group D, n = 23). Baseline demographics and laboratory parameters were collected. Using the in situ amniotic fluid cell culture method, we recorded the culture duration, number of media changes, and total cell yield. Pregnancy outcomes were subsequently tracked. Statistical analyses were performed using one-way analysis of variance, chi-square tests, and binary logistic regression. Results There were statistically significant differences between the four groups in terms of RBC, CRP, culture cycle, number of fluid changes, cell count, and history of bleeding during pregnancy (all P < 0.05). Among them, RBC and CRP levels were significantly different among the four groups. Group D had the highest RBC level, which was (4.93 ± 1.55)× 1012/L, which was significantly higher than other groups (F = 5.20, P = 0.002); group B had the highest CRP level, which was (9.63 ± 2.87) mg/L, and the difference between the four groups was statistically significant (F = 5.69, P = 0.001). In terms of culture-related indicators, there were significant differences among the four groups in terms of culture cycle, number of medium changes, and cell count (all P < 0.001). Group D had the longest culture period, (13.52 ± 0.88) days; the most number of medium changes, (5.57 ± 0.650) times; and the lowest cell count, (1.09 ± 0.56)× 105/mL. There were no statistically significant differences in conception methods, history of anticoagulant use, twin reduction, and placental position among the four groups (all P > 0.05). The distribution of history of bleeding during pregnancy was significantly different among the four groups (χ2 = 14.04, P = 0.003). Binary logistic regression model analysis showed that RBC, culture cycle, number of fluid changes, history of bleeding during pregnancy were significantly related to the occurrence of group D (OR = 2.27, 6.89, 4.25, 4.88 respectively). Pregnancy outcomes showed that adverse events such as miscarriage, amniotic fluid leakage, and premature birth occurred in group D, while no adverse events occurred in the other three groups. Conclusions Amniotic fluid sediment characteristics exhibit significant variations during the second trimester. Specifically, dark-brown sediment is associated with impaired in vitro cell culture efficiency and an increased risk of adverse pregnancy outcomes. These findings underscore the necessity for early risk assessment, stratified specimen processing, and individualized prenatal management in clinical practice.

Cite this article

Qin LI , Wei CHEN , Renhua WU , Jing YUAN , Yanping? HU . Factors influencing the characteristics of amniotic fluid sediment during mid-trimester amniocentesis and their impact on cell culture and pregnancy outcomes[J]. The Journal of Practical Medicine, 2026 , 42(15) : 2770 -2778 . DOI: 10.3969/j.issn.1006-5725.2026.15.013

References

[1] KIM N, JOO E H, KIM S, et al. Comparative analysis of obstetric, perinatal, and neurodevelopmental outcomes following chorionic villus sampling and amniocentesis[J]. Front Med, 2024, 11:1407710. doi: 10.3389/fmed.2024.1407710 .
[2] GOTO S, SUZUMORI N, KUMAGAI K, et al. Trends of fetal chromosome analysis by amniocentesis before and after beginning of noninvasive prenatal testing: A single-center experience in Japan[J]. J Obstet Gynaecol Res, 2021, 47(11): 3807-3812. doi: 10. 1111/jog.14965 .
[3] 方玉琴, 张苗苗, 李景然, 等. 基于毛细管电泳平台的单基因病携带者筛查应用[J]. 实用医学杂志, 2022, 38(23): 2973-2979. doi: 10.3969/j.issn.1006-5725.2022.23.015 .
[4] REZAGHOLI P, RASOULI M A, ZARE , S. Indications of Amniocentesis and its Early and Late Complications[J]. Adv Biomed Res, 2024, 13: 103. doi: 10.4103/abr.abr40823.
[5] BETA J, LESMES-HEREDIA C, BEDETTI C, et al. Risk of miscarriage following amniocentesis and chorionic villus sampling: A systematic review of the literature[J]. Minerva Ginecol, 2018, 70(2): 215-219. doi: 10.23736/S0026-4784.17.04178-8 .
[6] 邓国生, 何才通, 赖玉青. 改良同步化G显带及染色体微阵列分析在脐血产前诊断中的应用[J]. 实用医学杂志, 2021, 37(24): 3168-3173. doi: 10.3969/j.issn.1006-5725.2021.24. 014 .
[7] SHORT D, SHETH S, KELLEHER M, et al. The safety, acceptability, and success rates of amniocentesis in the context of preterm prelabor rupture of membranes and threatened preterm labor: a systematic review and meta-analysis[J]. J Matern Fetal Neonatal Med, 2024, 37(1): 2332784. doi: 10.1080/14767058.2024. 2332784 .
[8] 冯艺帆, 王云梦, 马婵婵. 全自动滴片在羊水细胞染色体制备中的应用价值[J]. 实用医学杂志. 2023, 39(6): 667-671. doi: 10.3969/j.issn.1006-5725.2023.06.003 .
[9] SIMMONS P M, WHITTINGTON J R, ESTRADA S M, et al. What is the Impact of Abnormal Amniotic Fluid Volumes on Perinatal Outcomes in Normal Compared with At-Risk Pregnancies?[J]. Int J Womens Health, 2020, 12: 805-812. doi: 10.2147/IJWH.S263329 .
[10] DAMMANN A N, CHAMBY A B, CATOMERIS A J, et al. Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits[J]. PLoS Pathog, 2021, 17(3): e1009116. doi: 10.1371/ journal.ppat.1009116 .
[11] 曾艳, 范佳鸣, 张丽芳. 产前诊断中羊水性状对羊水细胞培养的影响[J]. 中华妇产科杂志, 2016, 51(10): 779-782. doi: 10.3760/cma.j.issn.0529-567x.2016.10.014 .
[12] RAHMAWATI A, WULANDARI R C L, ARISANTI A Z, et al. The Effect of Date Juice and Honey OnIncreasing Hemoglobin in Pregnant Women with Anemia[J]. Int J Islamic Complemen Med, 2022, 3(2): 57-64. doi: 10.55116/ijicm.v3i2.43 .
[13] LOUKAS N, VRACHNIS D, ANTONAKOPOULOS N, et al. Prenatal Exposure to Bisphenol A: Is There an Association between Bisphenol A in Second Trimester Amniotic Fluid and Fetal Growth?[J]. Medicina. 2023, 59(5): 882. doi: 10.3390/medicina59050882 .
[14] WU J, LU Y, ZHENG Z, et al. A primary study: high-throughput sequencing analysis of amniotic fluid microbiota in 50 high-risk pregnant women during the second trimester[J]. Front Cell Infect Microbiol, 2026, 16: 1748232. doi: 10.3389/fcimb.2026. 1748232 .
[15] 陈晓玲,黄向贵,周泳宜,等. 宫内高血糖对新生儿炎症因子水平及婴儿过敏性疾病发生的影响[J]. 新医学,2024,55(6):437-442.doi:10.3969/j.issn.0253-9802.2024.06.006 .
[16] ROMERO R, GERVASI M T, DIGIULIO D B, et al. Are bacteria, fungi, and archaea present in the midtrimester amniotic fluid?[J]. J Perinat Med, 2023,51 (7): 886-890. doi: 10.1515/jpm-2022-0604 .
[17] CAMPESI I, CAPOBIANCO G, CANO A, et al. Stratification of Amniotic Fluid Cells and Amniotic Fluid by Sex Opens Up New Perspectives on Fetal Health[J]. Bio medicines, 2023, 11(10): 2830. doi: 10.3390/biomedicines11102830 .
[18] ZEMBALA-SZCZERBA M, JAWOROWSKI A, HURAS H, et al. Low-Grade Metabolically-Induced Inflammation Mediators Interleukin-6, Adiponectin, and TNF-α Serum Levels in Obese Pregnant Patients in the Perinatal Period[J]. Med Sci Monit Basic Res, 2017, 23: 1-7. doi: 10.12659/msmbr.902273 .
[19] WARINTAKSA P, ROMERO R, LERTRAT W, et al. Quantitative cervicovaginal fluid fetal fibronectin: A liquid biopsy for intra-amniotic inflammation[J]. Acta Obstet Gynecol, 2024, 103(11): 2252-2263. doi: 10.1111/aogs.14899 .
[20] GOMEZ-LOPEZ N, ROMERO R, XU Y, et al. The immunophenotype of amniotic fluid leukocytes in normal and complicated pregnancies[J]. Am J Reprod Immunol, 2018, 79(4): e12827. doi: 10. 1111/aji.12827 .
[21] JUNG E J, ROMERO R, GOMEZ-LOPEZ N, et al. Cervical insufficiency, amniotic fluid sludge, intra-amniotic infection, and maternal bacteremia: the need for a point-of-care test to assess inflammation and bacteria in amniotic fluid[J]. J Matern Fetal Neonatal Med, 2022, 35(24): 4775-4781. doi: 10.1080/14767058.2020. 1863369 .
[22] GOTO M, NAKAMURA M, TAKITA H, et al. Study for risks of amniocentesis in anterior placenta compared to placenta of other locations[J]. Taiwan J Obstet Gynecol, 2021, 60(4): 690-694. doi: 10.1016/j.tjog.2021.05.018 .
Outlines

/